ARCHIVES

ONS Continue Growth, Associate Category Defeated Again

This article is from The Cancer Letter archive.

Vol. 13 No. 20 | May 15, 1987

Download PDF Visit The Full Archive

Related Articles

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

Immune Systems Don’t Stop, Causing Fatigue For Survivors

May 26, 2006

Herberman Leaving NCI To Head New Pittsburgh Institute

July 12, 1985

In Brief: NCI Monograph On Year 2000 Objectives Now Available; Radiation Accident Workshop Planned

October 31, 1986